Back to top

Image: Bigstock

NuVasive (NUVA) in Focus: Stock Moves 8.4% Higher

Read MoreHide Full Article

NuVasive, Inc.  was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $50.58–$56.95 in the past one-month time frame, witnessed a sharp increase yesterday.

The move came after the company reported better-than-expected third-quarter results and announced a major stock repurchase program.

The Zacks Consensus Estimate for the current quarter has moved higher over the past one month, suggesting that more solid trading could be ahead for NuVasive. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road. 

NuVasive currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is positive.

NuVasive, Inc. Price and Consensus

A better ranked stock in the Medical - Products industry is Terumo Corp. (TRUMY - Free Report) which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is NUVA going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Terumo Corp. (TRUMY) - free report >>

Published in